GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Swedish Orphan Biovitrum AB (MEX:SOBI N) » Definitions » Inventories, Other

Swedish Orphan Biovitrum AB (MEX:SOBI N) Inventories, Other : MXN8,397 Mil (As of Jun. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Swedish Orphan Biovitrum AB Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Swedish Orphan Biovitrum AB's other inventories for the quarter that ended in Jun. 2025 was MXN8,397 Mil.

Swedish Orphan Biovitrum AB's quarterly other inventories increased from Dec. 2024 (MXN-2 Mil) to Mar. 2025 (MXN7,842 Mil) and increased from Mar. 2025 (MXN7,842 Mil) to Jun. 2025 (MXN8,397 Mil).

Swedish Orphan Biovitrum AB's annual other inventories increased from Dec. 2022 (MXN0 Mil) to Dec. 2023 (MXN2 Mil) but then declined from Dec. 2023 (MXN2 Mil) to Dec. 2024 (MXN-2 Mil).

Swedish Orphan Biovitrum AB Inventories, Other Historical Data

The historical data trend for Swedish Orphan Biovitrum AB's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Swedish Orphan Biovitrum AB Inventories, Other Chart

Swedish Orphan Biovitrum AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.65 -1.90

Swedish Orphan Biovitrum AB Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,517.81 7,688.25 -1.90 7,841.83 8,396.84

Swedish Orphan Biovitrum AB Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Swedish Orphan Biovitrum AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Swedish Orphan Biovitrum AB (MEX:SOBI N) » Definitions » Inventories, Other
Comparable Companies
OSTO:BIOG B OSTO:CRNO B OSTO:EQL OSTO:DICOT OSTO:CINPHA OSTO:ORX OSTO:ENZY OSTO:MOB OSTO:NANEXA XSAT:ACUC ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
SWOBY:USA BIOVF:USA SOBI:Sweden 1SOBI:Italy SOBIs:UK 0MTD:UK B6E:Germany
Address
Tomtebodavagen 23 A, Solna, Stockholm, SWE, SE-112 76
Website
https://www.sobi.com
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) in 2006 on long-acting hemophilia factor replacement programs. Biovitrum acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched hemophilia products Alprolix and Eloctate in Europe in 2016, and Altuvoct in 2024. Sobi has been building its immunology pipeline (rare-disease drug Gamifant, US rights to RSV antibodies Synagis and Beyfortus, gout drug SEL-212, complement drug Aspaveli) and a broader hematology pipeline (thrombocytopenia drug Doptelet, blood cancer drug Zynlonta, myelofibrosis drug Vonjo).

Swedish Orphan Biovitrum AB Headlines

No Headlines